Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients

被引：1
|
作者：
Sriram, Krishna [1 ]
Insel, Paul A. [1 ,2 ]
机构：
[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
来源：
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY | 2020年 / 319卷 / 01期
关键词：
D O I：
10.1152/ajplung.00262.2020
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：L37 / L38
页数：2
相关论文
共 50 条
  • [1] ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19
    Tetlow, S.
    Segiet-Swiecicka, A.
    O'Sullivan, R.
    O'Halloran, S.
    Kalb, K.
    Brathwaite-Shirley, C.
    Alger, L.
    Ankuli, A.
    Baig, M. S.
    Catmur, F.
    Chan, T.
    Dudley, D.
    Fisher, J.
    Iqbal, M. U.
    Puczynska, J.
    Wilkins, R.
    Bygate, R.
    Roberts, P.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2021, 289 (05) : 688 - 699
  • [2] Ace Inhibitors, Angiotensin Receptor Blockers, and Outcomes in Hospitalized Patients With Severe Covid-19 Pneumonia
    Grewal, Prabhjot
    Yoo, Jeanwoo
    Papamanoli, Aikaterini
    Mojahedi, Azad
    Dhaliwal, Simrat
    Nakamura, Jacquelyn
    Abata, Joshua
    Robin, Jacob
    Fung, Jenny
    Hotelling, Jessica
    Rawal, Sahil
    Karkala, Nikitha
    Tsui, Stella T.
    Coritsidis, Alexandra
    Marcos, Luis
    Bloom, Michelle E.
    Skopicki, Hal
    Kalogeropoulos, Andreas P.
    [J]. CIRCULATION, 2020, 142
  • [3] The Use Of Ace Inhibitors And Angiotensin Receptor Blockers Is Associated With Decreased Mortality And Increased Hospitalization Rate In Covid-19 Patients
    Douen, Aaron
    Oh, Jeremy
    Romney, Wesley
    Panetti, Ryan
    Ramdass, Prakash
    Toreli, Aleksandre
    Juang, George
    [J]. HYPERTENSION, 2021, 78
  • [4] In-hospital use of ACE inhibitors/angiotensin receptor blockers associates with COVID-19 outcomes in African American patients
    Li, Shilong
    Sarangarajan, Rangaprasad
    Jun, Tomi
    Kao, Yu-Han
    Wang, Zichen
    Hao, Ke
    Schadt, Emilio
    Kiebish, Michael A.
    Granger, Elder
    Narain, Niven R.
    Chen, Rong
    Schadt, Eric E.
    Li, Li
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (19):
  • [5] Effect of ACE inhibitors and angiotensin receptor blockers on in-hospital mortality and length of stay in hospitalized COVID-19 patients
    LaClair, Heather J.
    Khosrodad, Nadia
    Sule, Anupam A.
    Koehler, Tracy
    Krishnamoorthy, Geetha
    [J]. VASCULAR PHARMACOLOGY, 2021, 141
  • [6] ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19
    Wang, Yueying
    Tse, Gary
    Li, Guangping
    Lip, Gregory Y. H.
    Liu, Tong
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : 2041 - 2041
  • [7] Angiotensin receptor blockers and COVID-19
    Saavedra, Juan M.
    [J]. PHARMACOLOGICAL RESEARCH, 2020, 156
  • [8] Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients
    Mekary, Wissam
    Fares, Souha
    Abdulhai, Farah
    Massoud, Gaelle
    Refaat, Marwan
    Mericskay, Mathias
    Booz, George W.
    Zouein, Fouad A.
    [J]. HELIYON, 2023, 9 (09)
  • [9] Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
    Tian, Ci
    Li, Nan
    Bai, Yi
    Xiao, Han
    Li, Shu
    Ge, Qing-Gang
    Shen, Ning
    Ma, Qing-Bian
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (01) : 47 - 60
  • [10] Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
    Ci Tian
    Nan Li
    Yi Bai
    Han Xiao
    Shu Li
    Qing-Gang Ge
    Ning Shen
    Qing-Bian Ma
    [J]. World Journal of Clinical Cases, 2021, 9 (01) : 47 - 60
12345